Grants and Contributions

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

The attenuated grapevine leafroll-associated virus 3 will be developed by mutagenesis and tested for protection of GLRaV-3 free tissue culture against the infection of wild-type GLRaV-3 in the field.

This project will involve further development and characterization of oral bacTRL-based vaccines. This work includes the preclinical development of additional bacTRL-based products including emergent or predicted SARS-CoV-2 variants, as well as the continued evaluation of the lead vaccine candidate in a Phase I clinical trial.

Northern RNA is developing GMP manufacturing of mRNA and DNA based vaccines at our Calgary, Alberta based facility. GMP certification requires the development and documentation of all processes related to the manufacturing of product. It is our goal to be manufacturing 100 million doses of vaccines by early Q1 2022. This project is to document our proprietary GMP manufacturing processes and support the writing of the required Standard Operating Procedures (SOPs). This project will allow us to accelerate our GMP certification process to ensure we meet our goal of supplying 100 million doses of vaccines to domestic clients.

The purpose of this project is to provide employment for a recent Chemistry graduate in the role of Research Associate in a fast-growing and cutting-edge biotechnology company developing next generation therapeutics and vaccines.